脑部放疗,上午比下午敏感许多!
& V. K! H9 W7 w: P9 U" z: @% T5 G) J K/ Z: P
/ X( E0 ]+ _, Y i
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.; X4 l" D! w. T/ l$ v2 O( w. J
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?$ [" M: [- ^% s- R) n
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
0 ^! y! n b8 |0 B2 TSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.. v( g: r I; _3 O r* m; ]
! I% K0 a* w9 ^9 ~1 U. W1 w
Abstract
/ D; G5 q3 R% X8 t6 n) }BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time." ]7 g9 {6 `$ M4 q% }( d
! r0 y$ A+ r" q# `; w+ ^
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.6 p; F# P3 b X A3 n. h+ [' q) h
/ n, @2 Z6 S! [( j" `9 Y
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).2 j6 U. d! Q- W, G4 {8 z0 D* M
; w4 a* B$ T! g; |CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.8 P# d# R* F9 V+ b
. A9 s, j0 W; j3 h. V5 A' q |